- MCB 5670-02 Theory and Practice of Laboratory Techniques in Microbiology – Bacterial DNA & RNA Isolation and Quality Control
- MCB 5671-02 Advanced Theory and Practice of Laboratory Techniques in Microbiology – Characterization of Microbial Communities by 16S rRNA gene sequencing
Rachel J. O’Neill, Institute for Systems Genomics, Molecular & Cellular Biology, Genetics and Genome Sciences, College of Liberal Arts and Sciences to be inducted into the Connecticut Academy of Science and Engineering (CASE) for 2020.
Dr. Jeehee Youn, who earned her Ph.D. in Michael Lynes’ laboratory in 1996, was recently elected President of the Korean Association of Immunologists (KAI) for 2021. She currently serves as vice president of that scientific society. Dr. Youn is shown here at the far right in a photo of her lab group during a visit by Dr. Lynes to Hanyang University in Seoul, Korea.
Congratulations to the following MCB students – they have been awarded 2020 graduate and undergraduate summer fellowships:
Congratulations to the following MCB graduate students! Kristen Dostie, Rishabh Kejriwal, Virginia King, Amy Thees, Corey Theodore, and Jennifer Podgorski have been awarded a Spring 2020 Doctoral Student Travel Fellowship from the UConn Graduate School.
Biohaven Pharmaceuticals is a clinical/commercial-stage biopharmaceutical company located in New Haven, CT that is engaged in developing a portfolio of innovative, late-stage therapeutic candidate molecules that target, neurological and neuropsychiatric diseases, including rare disorders. They have new programs that reach into areas including migraine headache, inflammation and neurodegeneration.
Biohaven runs a novel summer internship program for undergraduate and graduate students who are interested in the evaluation of new therapeutics and the process of identifying new intellectual property that may have marketplace value. Biohaven will work with the intern to identify an aspect of the drug development process where the student can participate in Biohaven’s work. Applicants should submit a letter of interest, their transcripts, and a resume or C.V. to the department of Molecular and Cell Biology (email@example.com) for evaluation. Applications are due April 1, 2020.
Dr. Michael Lynes was recently selected to be a Fulbright Scholar and will work at the Center for Diabetes Research, University of Bergen (Norway) for the fall 2020 semester. He was also made a Senior Fellow of the Cell Stress Society International. Dr. Lynes has recently been awarded two new research grants: an NIH phase II STTR grant entitled “Measuring toxicant effects on cellular function in a microarray format” and a sponsored research award from Biohaven Pharmaceuticals to support the ongoing development of a therapeutic monoclonal antibody for chronic inflammation applications entitled “Characterization of UC1MT therapeutic antibody and its derivatives”.